Baxter International BAX Stock Purchasers File Securities Fraud Class Action Lawsuit Complaint Against Baxter Over Plasma-Derivative Products and COLLEAGUE Infusion Pump.
A securities fraud class action lawsuit has been filed against Baxter International, Inc. (“Baxter International” or “Baxter” or”BAX”” or “Defendant”) and certain Baxter officers and directors in the United States District Court for the Northern District of Illinois on behalf of a class consisting of all purchasers of Baxter common stock (symbol: BAX) during the period between September 17, 2009 and May 3, 2010, inclusive (the “Class Period”), alleging that Baxter and certain officers and directors violated federal securities laws, including the Securities and Exchange Act of 1934, by allegedly issuing false and misleading statements regarding Baxter’s plasma-derivative products business and regarding the remediation of Baxter’s COLLEAGUE infusion pump, according to class action lawsuit news reports.
If You Have Thoughts On The Baxter International Securities Fraud Class Action Lawsuit, Share Your Class Action Comments Below.